SEC Company Response from UMeWorld Inc. (UMEW) (CIK 0001114936) (UMEW) — Oct 1, 2004
UMeWorld Inc. (UMEW) (CIK 0001114936)
Date: Oct. 1, 2004 · CIK: 0001114936 · Accession: 0001144204-04-015578
AI Filing Summary & Sentiment
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
[LETTERHEAD OF PEDLEY ZIELKE GORDINIER & PENCE, PLLC]
ATTORNEYS AT LAW
2000 MEIDINGER TOWER
462 SOUTH FOURTH AVENUE
LOUISVILLE, KENTUCKY 40202-2555
(502) 589-4600
FAX (502) 584-0422
WWW.PZGP.COM
October 1, 2004
VIA EDGAR FILING
United States Securities and Exchange Commission
Division of Corporate Finance
450 Fifth Street, N.W.
Washington, D.C. 20549
Re: Response to Comments on the Registration Statement on Form SB-2 of
AlphaRx, Inc.
Dear Mr. Belliston:
The undersigned has acted as counsel to AlphaRx, Inc., during AlphaRx's
registration of securities on Form SB-2. We are in receipt of the Securities and
Exchange Commission's comment letter, dated September 17, 2004. In response to
your letter, please note that AlphaRx has made the following changes in its
first amendment to the registration statement:
1. In response to Comment #1, of your letter, AlphaRx has adjusted the
number of shares being registered in the selling security holders table
to reflect the correct number of 93,905,994 shares.
2. In response to Comment #2 of your letter, AlphaRx has identified all
broker-dealers as underwriters except for those broker-dealers whose
shares were issued as compensation for underwriting activities.
3. In response to Comment #3 of your letter, AlphaRx has noted that all
affiliates of all broker-dealers identified in the prospectus obtained
their shares in the ordinary course of business and that there is no
agreement or understanding with any person to distribute any shares.
4. In response to Comment #4 of your letter, AlphaRx has obtained consent
letters for both its present and past accountants and has submitted
those as exhibits to its amended registration statement.
Furthermore, AlphaRx acknowledges and understands that if the Commission
or its staff declare its filing effective that it does not foreclose the
Commission from taking
<PAGE>
PEDLEY ZIELKE GORDINIER & PENCE, PLLC
any action with respect to the filing, or relieve AlphaRx from its full
responsibility for the adequacy and accuracy of the disclosures contained in its
prospectus. Additionally, AlphaRx's understands and acknowledges that declaring
the prospectus effective does not allow AlphaRx to raise this fact as a defense
to any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
If you have any further questions or comments, please do not hesitate to
contact me.
Sincerely,
/s/ David M. Pedley
-------------------
David M. Pedley
</TEXT>
</DOCUMENT>